Elsevier

Physiotherapy

Volume 90, Issue 3, September 2004, Pages 120-124
Physiotherapy

A pilot study measuring mixed venous carbon dioxide levels in students with and without a diagnosis of asthma

https://doi.org/10.1016/j.physio.2004.05.003Get rights and content

Abstract

Objectives To pilot a protocol for measuring mixed venous carbon dioxide levels in individuals with asthma and establish likely values and variance for future power calculations.

Design Preliminary pilot study comparing two groups of individuals defined as asthmatic and non-asthmatic.

Setting Lung function laboratory in a regional teaching hospital.

Participants Eleven university students, five with a diagnosis of asthma and six with no known disorders.

Measurements Mixed venous carbon dioxide levels; spirometry.

Results Mixed venous carbon dioxide levels in the students with asthma ranged from 5.08 to 5.71 kPa (mean 5.35 kPa), and in the healthy students they ranged from 5.62 to 6.45 kPa (mean 6.01 kPa). The mean difference in mixed venous carbon dioxide levels between the two groups was 0.66 kPa (95% confidence interval 0.28–1.03).

Conclusion This pilot study has demonstrated that a protocol using non-invasive mixed venous carbon dioxide measures is acceptable to people with asthma. It has also added to the evidence suggesting that asthmatic individuals have lower levels of carbon dioxide than the healthy population, even when they are stable and asymptomatic.

Introduction

Physiotherapists frequently use breathing control techniques to treat patients with symptoms of overbreathing, including asthma, chronic obstructive pulmonary disease and hyperventilation syndrome. Despite the frequency of their use, there is little published data on the physiological effects of breathing control techniques on the respiratory system. Physiotherapists use these techniques based on the hypothesis that they will result in a rise in patients’ carbon dioxide (CO2) levels [1], and that this will ‘desensitise’ patients to CO2 and hence reduce the sensation of breathlessness. This hypothesis suggests a belief that individuals with symptoms of hyperventilation are hypocapnic (have low CO2 levels) compared to the healthy population. During acute episodes of asthma, hyperventilation leading to hypocapnia is well documented [2], [3], [4], but only two studies have suggested that patients with asthma are hypocapnic when their asthma is stable [5], [6].

Animal studies have found that reduction in alveolar CO2 produces an increase in airway resistance by inducing bronchospasm and increasing the permeability of microvessels in the airway [7]. Although hypocapnia is a consistent finding in acute asthma, it is not certain whether it has any clinically relevant pathogenic role. Proponents of the Buteyko breathing technique [8] would suggest that this is the case. Also, in 1968 it was hypothesised in the New England Journal of Medicine [9] that hypocapnia during an asthma attack could perpetuate the bronchospasm and lead to a cycle of progressive hypocapnia and increasing bronchospasm. There is a body of experimental evidence that supports this hypothesis. There is in vitro animal evidence suggesting that low CO2 causes bronchoconstriction [7] while a high CO2 acts directly on the airway smooth muscle to cause bronchodilatation [10]. However, the mechanism for the bronchoconstriction is still uncertain and may relate to the degree of hypocapnia. Sterling [11] found that when end tidal CO2 was less than about 30 mmHg (4 kPa) the bronchoconstriction was mediated via the autonomic nervous system, through the vagus nerve, but that when end tidal CO2 was less than 15 mmHg (2 kPa) it was mediated by direct effect on the airway muscle.

There is also support for the association between hypocapnia and bronchoconstriction from experimental evidence from humans [5], [11], [12], [13], [14]. Elshout et al. [5] studied the effects of hypercapnia and hypocapnia on respiratory resistance in both normal and asthmatic subjects. They found that a reduction in end tidal CO2 of only 1 kPa caused an increase in resistance by 13% and a fall in reactance by 45%, while the same reduction in CO2 had no effect on healthy subjects. Conversely an increase in end tidal CO2 of only 1 kPa resulted in a significant fall in airway resistance in both asthmatic and normal subjects. Bayindir et al. [15] have reported on the adverse effects of hypocapnia during cardiopulmonary bypass, which led to an increase in airway resistance and a reduction in lung compliance.

Section snippets

Aim

The purpose of this pilot study was to trial an alternative methodology for the measurement of CO2 levels and to determine the likely values and variance using this technique. This data would then be used to assist in producing power calculations for a more definitive study to determine whether individuals with asthma have lower CO2 levels than healthy individuals. This study was presented at the World Confederation for Physical Therapy conference in 2003 [16] and is now reported more fully

Sample size

As this was a preliminary pilot study, power calculations were not appropriate to determine sample size and the aim was to recruit a convenience sample of 12 participants.

Recruitment

Participants were recruited via posters placed in student areas around the University of Southampton. Inclusion criteria were that all participants should be aged 18 or over, non-smokers, and asymptomatic from respiratory tract infections. Inclusion criteria for the asthma participants were that they considered themselves to

Results

Table 1 provides the descriptive data for the participants. On average, the healthy students were taller and heavier than those with asthma. In the students with asthma, percentage predicted FEV1 ranged from 84% to 112% (mean 98%) and mixed venous CO2 levels ranged from 5.08 to 5.71 kPa (mean 5.35 kPa). in the healthy students percentage predicted FEV1 ranged from 102% to 115% (mean 107%) and mixed venous CO2 levels ranged from 5.62 to 6.45 kPa (mean 6.01 kPa). The mean difference in mixed venous CO

Discussion

This preliminary pilot study has tested an indirect method for assessing arterial CO2 in individuals with a diagnosis of asthma. However, there was no formal determination of a diagnosis of asthma in the asthma group, or of good health in the control group. Participants’ own statements about their health status were accepted, which may have led to some participants being assigned to the ‘wrong’ group. However, there is no universally accepted objective test for the diagnosis of asthma [21], [22]

Conclusion

The gold standard measure for CO2 levels is arterial blood gas analysis, but mixed venous CO2 is an accepted alternative [19] that provides a reproducible and reliable indirect measurement of arterial CO2. This pilot study has demonstrated that a protocol using non invasive mixed venous CO2 measures is acceptable to people with asthma. It has also added to the evidence suggesting that asthmatic individuals have lower levels of CO2 than the healthy population, even when they are stable and

Acknowledgements

The authors are indebted to John Heath of the Pulmonary Function Laboratory, Southampton General Hospital for his assistance in the recording and analysing of the mixed venous carbon dioxide data.

References (28)

  • W.N. Gardner

    The pathophysiology of hyperventilation disorders

    Chest

    (1996)
  • Pryor JA, Webber BA. Physiotherapy for respiratory and cardiac problems. Edinburgh: Churchill Livingstone;...
  • J.G. Laffey et al.

    Hypocapnia

    New Engl. J. Med.

    (2002)
  • R. Rodriguez-Roisin

    Gas exchange abnormalities in asthma

    Lung

    (1990)
  • J.A. Odhiambo et al.

    Arterial blood gases and acid-base status of adult patients presenting with acute severe asthma at Kenyatta National Hospital, Nairobi

    East African Med. J.

    (1992)
  • F.J. van den Elshout et al.

    Effects of hypercapnia and hypocapnia on respiratory resistance in normal and asthmatic subjects

    Thorax

    (1991)
  • C.A. Osborne et al.

    Hyperventilation and asymptomatic chronic asthma

    Thorax

    (2000)
  • A.M. Reynolds et al.

    Tachykinins mediate hypocapnia-induced bronchoconstriction in guinea pigs

    J. Appl. Physiol.

    (1989)
  • Stalmatski A. Freedom from asthma: Buteyko’s revolutionary treatment. London: Kyle Cathie Ltd.;...
  • Hypoxemia and hypocapnia in asthma. New Engl J Med...
  • E. D’Angelo et al.

    The effects of CO2 on respiratory mechanics in anesthetized paralyzed humans

    Anesthesiology

    (2001)
  • G.M. Sterling

    The mechanism of bronchoconstriction due to hypocapnia in man

    Clin. Sci.

    (1968)
  • M.T. Newhouse et al.

    Effect of alterations in end-tidal CO2 tension on flow resistance

    J. Appl. Physiol.

    (1964)
  • C.F. O’Cain et al.

    J. Appl. Physiol.

    (1979)
  • Cited by (5)

    • The use of mouth taping in people with asthma: a pilot study examining the effects on end-tidal carbon dioxide levels

      2007, Physiotherapy
      Citation Excerpt :

      They report some benefits, such as a reduction in symptoms and medication use, and a trend towards an improvement in quality of life, but the evidence is still inconclusive. Classical Buteyko theory proposes that the cause of asthma is a primary pathological hyperventilation leading to a low alveolar partial pressure of carbon dioxide (PCO2) [8], and suggests that bronchoconstriction is the body's defence mechanism against losing CO2. Based on this theory, practitioners teach people with asthma to hypoventilate to elevate PCO2, theoretically encouraging bronchodilation and desensitising patients to CO2[8].

    • Preliminary investigations into the effects of breathing retraining techniques on end-tidal carbon dioxide measures in patients with asthma and healthy volunteers during a single treatment session

      2007, Physiotherapy
      Citation Excerpt :

      Patients with hyperventilation symptoms are frequently referred to physiotherapists for breathing retraining. One of the physiological hypotheses underpinning this practice is that such patients either have lower levels of carbon dioxide or are more sensitive to carbon dioxide than healthy individuals [1]. Although this theory has been accepted by many clinicians, there is very little evidence to support it at the present time.

    • Ventilatory techniques in asthma: A literature review

      2015, Revista de Patologia Respiratoria
    View full text